Singapore: Phylogica, a leading Australian peptide drug discovery company, is expanding its collaboration with Janssen B...
Singapore: CSL has developed a new drug candidate that is able to prevent the development of type 2 diabetes and revers...
Asia's two leading economies, India and China are actively working on new strategies to attract money into the bioscienc...
Singapore: Australia-based QRxPharma has collaborated with Aesica Formulation Development for the world-wide promotion o...
Singapore: Medical Device and Diagnostic Industry (MD+DI) recently published an original infographic and supporting arti...
Singapore: Australia based Ascend Biopharmaceuticals has collaborated with 3M Drug Delivery Systems to evaluate 3M's Tol...
Singapore: Fovia Medical, a world leader in volume rendering technology, and Contrast Imaging, a leading Australian pro...
Singapore: Australian infectious disease therapy development company BioDiem signed an agreement with Griffith Universi...
Singapore: pSivida, a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye di...
Singapore: Australia-based contract research organization, Novotech, recently announced that it has expanded its Hong Ko...
Singapore: Cochlear has received the US Food & Drug Administration (FDA) approval for its Nucleus CI422 with Slim St...
Singapore: REVA Medical, listed with the ASX, has appointed Dr David Muller, director, Cardiac Catheterization at St Vin...
Singapore: Australia Patrys, a clinical stage biopharmaceutical company, has received approval to commence its planned P...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: The Australian Institute for Bioengineering and Nanotechnology (AIBN) entered into research collaboration wit...
Singapore: Apollo's Medical e-learning initiative, Medvarsity, has tied up with University of New South Wales (UNSW),to ...
Singapore: Merck, which is known as MSD outside the US and Canada, revealed positive results from its phase Ib study sho...
Singapore: Viralytics has finalized the clinical study report on the phase I evaluation of Cavatak, which is administere...
